Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT

NCT02062723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 515

Last updated 2014-02-14

No results posted yet for this study

Summary

The efficacy and tolerability of Eptadone® in the context of a maintenance program will be evaluated in an observational prospective, multicenter study, in heroin addicted patients.

Conditions

  • Heroin Addiction

Sponsors & Collaborators

  • L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062723 on ClinicalTrials.gov